Letters to the Editor

Published in:
Volume 5 / Year 2016 / Issue 1

First biosimilar of infliximab approved in Brazil: response from the Brazilian IBD society

Page: 4-5

Abstract: CT-P13 was the first infliximab biosimilar approved in Brazil. Approval was granted for all indications of the innovator. Despite similar efficacy and safety, vigilance remains essential. Submitted: 4 January… Read More »

Go Back Print